FDA Application
-
NDC Search Results on Active Ingredient: acetaminophen
Click on Active Ingredient to view the label.
Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
---|---|---|---|---|---|
ACETAMINOPHEN | 24385-484-78 | Amerisource Bergen | part343 | HUMAN OTC DRUG | OTC monograph not final |
ACETAMINOPHEN | 24385-484-90 | Amerisource Bergen | part343 | HUMAN OTC DRUG | OTC monograph not final |
PYRILAMINE MALEATE; CAFFEINE; ACETAMINOPHEN | 24689-121-01 | APNAR PHARMA LP | part343 | HUMAN OTC DRUG | OTC monograph not final |
PYRILAMINE MALEATE; CAFFEINE; ACETAMINOPHEN | 24689-121-02 | APNAR PHARMA LP | part343 | HUMAN OTC DRUG | OTC monograph not final |
DEXTROMETHORPHAN HYDROBROMIDE; ACETAMINOPHEN; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE | 24689-152-01 | APNAR PHARMA LP | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN | 25000-071-02 | MARKSANS PHARMA LIMITED | ANDA215486 | HUMAN OTC DRUG | ANDA |
ACETAMINOPHEN | 25000-071-08 | MARKSANS PHARMA LIMITED | ANDA215486 | HUMAN OTC DRUG | ANDA |
ACETAMINOPHEN | 25000-071-10 | MARKSANS PHARMA LIMITED | ANDA215486 | HUMAN OTC DRUG | ANDA |
ACETAMINOPHEN | 25000-071-11 | MARKSANS PHARMA LIMITED | ANDA215486 | HUMAN OTC DRUG | ANDA |
ACETAMINOPHEN | 25000-071-45 | MARKSANS PHARMA LIMITED | ANDA215486 | HUMAN OTC DRUG | ANDA |
ACETAMINOPHEN; IBUPROFEN | 25000-080-07 | MARKSANS PHARMA LIMITED | ANDA216994 | HUMAN OTC DRUG | ANDA |
ACETAMINOPHEN; IBUPROFEN | 25000-080-72 | MARKSANS PHARMA LIMITED | ANDA216994 | HUMAN OTC DRUG | ANDA |
ACETAMINOPHEN; IBUPROFEN | 25000-080-74 | MARKSANS PHARMA LIMITED | ANDA216994 | HUMAN OTC DRUG | ANDA |
ACETAMINOPHEN | 25000-108-02 | MARKSANS PHARMA LIMITED | ANDA215486 | HUMAN OTC DRUG | ANDA |
ACETAMINOPHEN | 25000-108-08 | MARKSANS PHARMA LIMITED | ANDA215486 | HUMAN OTC DRUG | ANDA |
ACETAMINOPHEN; HYDROCODONE BITARTRATE | 27808-035-01 | Tris Pharma Inc | ANDA202214 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; HYDROCODONE BITARTRATE | 27808-035-02 | Tris Pharma Inc | ANDA202214 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; HYDROCODONE BITARTRATE | 27808-035-03 | Tris Pharma Inc | ANDA202214 | HUMAN PRESCRIPTION DRUG | ANDA |
HYDROCODONE BITARTRATE; ACETAMINOPHEN | 27808-036-01 | Tris Pharma Inc | ANDA202214 | HUMAN PRESCRIPTION DRUG | ANDA |
HYDROCODONE BITARTRATE; ACETAMINOPHEN | 27808-036-02 | Tris Pharma Inc | ANDA202214 | HUMAN PRESCRIPTION DRUG | ANDA |
HYDROCODONE BITARTRATE; ACETAMINOPHEN | 27808-036-03 | Tris Pharma Inc | ANDA202214 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; HYDROCODONE BITARTRATE | 27808-037-01 | Tris Pharma Inc | ANDA202214 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; HYDROCODONE BITARTRATE | 27808-037-02 | Tris Pharma Inc | ANDA202214 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; HYDROCODONE BITARTRATE | 27808-037-03 | Tris Pharma Inc | ANDA202214 | HUMAN PRESCRIPTION DRUG | ANDA |
HYDROCODONE BITARTRATE; ACETAMINOPHEN | 27808-049-01 | Tris Pharma Inc | ANDA201295 | HUMAN PRESCRIPTION DRUG | ANDA |
HYDROCODONE BITARTRATE; ACETAMINOPHEN | 27808-114-01 | Tris Pharma Inc | ANDA202214 | HUMAN PRESCRIPTION DRUG | ANDA |
HYDROCODONE BITARTRATE; ACETAMINOPHEN | 27808-114-02 | Tris Pharma Inc | ANDA202214 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; HYDROCODONE BITARTRATE | 27808-115-01 | Tris Pharma Inc | ANDA202214 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; HYDROCODONE BITARTRATE | 27808-115-02 | Tris Pharma Inc | ANDA202214 | HUMAN PRESCRIPTION DRUG | ANDA |
HYDROCODONE BITARTRATE; ACETAMINOPHEN | 27808-116-01 | Tris Pharma Inc | ANDA202214 | HUMAN PRESCRIPTION DRUG | ANDA |
-